PFE - As more rare disease therapies launch their prices are rising
2024-04-16 12:22:50 ET
More on rare disease pharmas/biotechs
- Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy
- Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts
- Ultragenyx Pharmaceutical Earnings: No Visible Path To Financial Success Yet
- Arcturus Therapeutics Q4 2023 Earnings Preview
- Sarepta Therapeutics Q4 2023 Earnings Preview